Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Avidity in antibody effector functions and biotherapeutic drug design. | Nat Rev Drug Discov | 2022 | 35790857 | PubTator, text mining | PubMed |
| Pneumonia in Nervous System Injuries: An Analytic Review of Literature and Recommendations. | Cureus | 2022 | 35784955 | PubTator, text mining | PubMed |
| Long-Term Efficacy of Non-steroid Immunosuppressive Agents in Anti-Muscle-Specific Kinase Positive Myasthenia Gravis Patients: A Prospective Study. | Front Neurol | 2022 | 35775051 | PubTator, text mining | PubMed |
| A Rare Case of Leptomeningeal Carcinomatosis Secondary to Metastatic Non-Small Cell Lung Carcinoma. | Cureus | 2022 | 35774640 | PubTator, text mining | PubMed |
| Risk of Autoimmune Diseases Following Optic Neuritis: A Nationwide Population-Based Cohort Study. | Front Med (Lausanne) | 2022 | 35770018 | PubTator, text mining | PubMed |
| Amifampridine safety and efficacy in spinal muscular atrophy ambulatory patients: a randomized, placebo-controlled, crossover phase 2 trial. | J Neurol | 2022 | 35763114 | PubTator, text mining | PubMed |
| Prediction of the generalization of myasthenia gravis with purely ocular symptoms at onset: a multivariable model development and validation. | Ther Adv Neurol Disord | 2022 | 35755967 | PubTator, text mining | PubMed |
| Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis. | Front Med (Lausanne) | 2022 | 35755064 | PubTator, text mining | PubMed |
| Electrodiagnostic Characteristics Suggestive of Muscle-Specific Kinase Myasthenia Gravis. | Neurol Clin Pract | 2022 | 35747537 | PubTator, text mining | PubMed |
| Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy. | Biomedicines | 2022 | 35740382 | PubTator, text mining | PubMed |
| Rituximab in Refractory Myositis and Acute Neuropathy Secondary to Checkpoint Inhibitor Therapy. | Cureus | 2022 | 35733495 | PubTator, text mining | PubMed |
| Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis. | Neurol Neuroimmunol Neuroinflamm | 2022 | 35728947 | PubTator, text mining | PubMed |
| Simultaneous resection of coexisting pulmonary and mediastinal lesions by video-assisted thoracic surgery: a case-series study. | BMC Surg | 2022 | 35725438 | PubTator, text mining | PubMed |
| Integrating Mechanisms of Exacerbated Atrophy and Other Adverse Skeletal Muscle Impact in COPD. | Front Physiol | 2022 | 35721564 | PubTator, text mining | PubMed |
| A Rare Case of Guillain-Barré Syndrome Associated With SARS-CoV-2 Infection Requiring Mechanical Ventilation. | Cureus | 2022 | 35720780 | PubTator, text mining | PubMed |
| Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings. | Front Neurol | 2022 | 35720108 | PubTator, text mining | PubMed |
| Cryo-electron Microscopic Analysis of Single-Pass Transmembrane Receptors. | Chem Rev | 2022 | 35715229 | PubTator, text mining | PubMed |
| Clinical implication of denervation in sporadic inclusion body myositis. | J Neurol Sci | 2022 | 35709642 | PubTator, text mining | PubMed |
| A network-based pharmacological study on the mechanism of action of muscone in breast cancer. | Transl Cancer Res | 2022 | 35706803 | PubTator, text mining | PubMed |
| In Vitro Insertional Mutagenesis Screen Identifies Novel Genes Driving Breast Cancer Metastasis. | Mol Cancer Res | 2022 | 35687718 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=42